Compound reference

IGF-1 DES (1-3)

A truncated variant of IGF-1 missing its first three amino acids, studied in animals and cell culture as a research reagent.

Updated October 2026 · 3 minute read
This page is an educational reference, not medical advice. IGF-1 DES(1-3) is a research reagent and is not approved by the FDA for human use.

What it is

IGF-1 DES(1-3) is a variant of IGF-1 missing the three amino acids at its start (Gly-Pro-Glu). The truncation sharply reduces binding to IGF-binding proteins, the blood proteins that bind and carry IGF-1, which makes the peptide more active locally but short-lived.

It is used as a research reagent rather than a clinical drug, with essentially no human trial data. In the PeptidesAI encyclopedia it is categorized under growth hormone.

How it's thought to work

IGF-1 DES(1-3) activates the IGF-1 receptor to drive protein synthesis and satellite cell activation, where satellite cells are the stem cells of muscle tissue. Because it binds IGF-binding proteins poorly, more of the peptide is free and active at the site of administration, but it is cleared rapidly, giving it a short half-life.

In cell culture, des(1-3)IGF-I has been reported to be about 10-fold more potent than IGF-1 at stimulating hypertrophy and proliferation, a consequence of its much reduced binding to IGF-binding proteins.

What the research says

IGF-1 biology is extensively studied, but DES(1-3) itself is a laboratory reagent with no clinical development program. It is not FDA-approved.

In pigs and marmoset monkeys, des(1-3)IGF-I lowered blood glucose 2- to 3-fold more strongly than IGF-1 and over a longer period.

Reported side effects

Reported side effects include hypoglycemia (low blood sugar), injection site reactions and headache. A theoretical concern is that growth-factor signaling could promote unwanted tissue growth. The animal glucose-lowering findings above are consistent with the hypoglycemia concern.

Reconstitution

IGF-1 DES (1-3) is supplied as a lyophilized (freeze-dried) powder and is typically reconstituted with bacteriostatic (BAC) water before use. It commonly comes in 1 mg vials. The amount of peptide in the vial is fixed; the water added only changes how concentrated the solution is.

Worked example. A 1 mg vial is 1,000 mcg. Reconstituted with 2 mL of BAC water, that works out to 1,000 mcg ÷ 2 mL = 500 mcg/mL. On a U-100 insulin syringe, where each unit is 0.01 mL, each unit holds 500 × 0.01 = 5 mcg. Use the peptide reconstitution calculator to work out the concentration and units for any vial size and water volume.

Important notes

IGF-1 DES(1-3) is a growth factor with significant safety considerations, including hypoglycemia and a theoretical risk of tissue growth. It is not FDA-approved and is listed as prohibited by the World Anti-Doping Agency (WADA).

Sources

  1. Des(1-3)IGF-I: a truncated form of insulin-like growth factor-I. Ballard FJ et al. International Journal of Biochemistry & Cell Biology, 1996. Review
  2. IGF-I variants which bind poorly to IGF-binding proteins show more potent and prolonged hypoglycaemic action than native IGF-I in pigs and marmoset monkeys. Tomas FM et al. Journal of Endocrinology, 1997. Preclinical

How we choose and check sources

Frequently asked questions

These questions cover the same ground as the sections above, in a shorter format.

What is IGF-1 DES(1-3)?

An IGF-1 variant missing its first three amino acids, used as a research reagent with essentially no human trial data.

How is IGF-1 DES(1-3) thought to work?

It activates the IGF-1 receptor to drive protein synthesis and satellite cell activation; poor binding to IGF-binding proteins leaves more of it free at the site of administration, but it is cleared quickly.

What does the research on IGF-1 DES(1-3) say?

It is a laboratory reagent with no clinical development program; animal studies found it lowered blood glucose more strongly and for longer than IGF-1.

What are the reported side effects of IGF-1 DES(1-3)?

Hypoglycemia, injection site reactions and headache, plus a theoretical concern about unwanted tissue growth.

How much is one unit from a 1 mg IGF-1 DES (1-3) vial?

With 2 mL of BAC water, a 1 mg vial is 500 mcg/mL, so one unit on a U-100 syringe (0.01 mL) holds 5 mcg.

The full entry, plus the calculator

The PeptidesAI app has the complete encyclopedia entry for IGF-1 DES (1-3) — one of 70 compounds covered — plus the reconstitution calculator, a dose log and reminders. Free to download on iPhone.

Download on the App Store

Related